Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molex is a global leader in electronics and connectivity solutions with significant operations in healthcare through its subsidiaries Phillips-Medisize and Vectura. It offers end-to-end design, engineering, development, regulatory support, and large-scale manufacturing services for medical devices—including advanced drug delivery systems such as inhalers—and diagnostic tools. The company’s recent acquisition of Vectura further expands its capabilities in inhalation therapies for asthma/COPD. Its business model centers on partnering with pharmaceutical/biotech companies rather than developing proprietary therapeutics or diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molex.